Cholestyramine, a cost-effective yet efficacious anti-dote in digoxin toxicity

Document Type

Article

Department

Medicine; Internal Medicine; Biological and Biomedical Sciences; Community Health Sciences

Abstract

Digoxin is a cardiac glycoside obtained from digitalis lanata, is a positive inotropic and negative chronotropic agent. Digoxin works by blocking Na-K ATPase pump resulting in raised intracellular sodium which in turn raise intracellular calcium in the myocytes resulting in increase in inotropic effect [1, 2]. Digoxin causes several adverse effects in overdose leading to both bradyarrhythmias and tachyarrhythmias. The approved antidote, digoxin-specific antibody fragments (DIGIFAB), is costly yet effective option for managing digoxin toxicity [3] we describe the cases in which levels of digoxin fell to acceptable therapeutic levels with the use of Cholestyramine.

Publication (Name of Journal)

International Research Journal of Pharmacy and Medical Sciences (IRJPMS)

Link to Full Text

Share

COinS